Adello Biologics Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
125
- Latest Deal Type
-
M&A
Adello Biologics General Information
Description
Operator of a biotechnology company intended to provide affordable biosimilars to patients worldwide. The company utilizes approved biosimilars to make drugs that are similar in quality, safety and effectiveness to an existing branded biologic, enabling patients and providers to reduce costs and improve access to important treatments.
Contact Information
Website
www.adellobio.comCorporate Office
- 20 New England Avenue
- Piscataway, NJ 08854
- United States
Corporate Office
- 20 New England Avenue
- Piscataway, NJ 08854
- United States
Adello Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 03-Jan-2019 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Later Stage VC | 28-Jul-2010 | $8.4M | $9.4M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jul-2005 | $1M | $1M | Completed | Product Development |
Adello Biologics Comparisons
Industry
Financing
Details
Adello Biologics Competitors (14)
One of Adello Biologics’s 14 competitors is Formycon, a Formerly VC-backed company based in Martinsried, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Formycon | Formerly VC-backed | Martinsried, Germany | ||||
| mAbxience | Corporate Backed or Acquired | Madrid, Spain | ||||
| Nevian Lifescience | Corporate Backed or Acquired | Dhaka, Bangladesh | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ |
Adello Biologics Patents
Adello Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160091424-A1 | Blood analyzer and blood analyzing method | Active | 26-Sep-2014 | ||
| US-9500581-B2 | Blood analyzer and blood analyzing method | Active | 26-Sep-2014 | ||
| EP-3096744-A1 | Thermodynamic equivalence surrogate test (test) for bioequivalence | Inactive | 22-Jan-2014 | ||
| EP-3096744-A4 | Thermodynamic equivalence surrogate test (test) for bioequivalence | Inactive | 22-Jan-2014 | ||
| US-20140024105-A1 | Baffled single use bioreactor | Active | 21-Jul-2012 | C12M27/20 |
Adello Biologics Signals
Adello Biologics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capital Midwest Fund | Venture Capital | Minority | ||
| Tarsadia Investments | Family Office | Minority | ||
| University Technology Park | Accelerator/Incubator |
Adello Biologics FAQs
-
When was Adello Biologics founded?
Adello Biologics was founded in 2003.
-
Where is Adello Biologics headquartered?
Adello Biologics is headquartered in Piscataway, NJ.
-
What is the size of Adello Biologics?
Adello Biologics has 125 total employees.
-
What industry is Adello Biologics in?
Adello Biologics’s primary industry is Drug Discovery.
-
Is Adello Biologics a private or public company?
Adello Biologics is a Private company.
-
What is Adello Biologics’s current revenue?
The current revenue for Adello Biologics is .
-
How much funding has Adello Biologics raised over time?
Adello Biologics has raised $9.4M.
-
Who are Adello Biologics’s investors?
Capital Midwest Fund, Tarsadia Investments, and University Technology Park have invested in Adello Biologics.
-
Who are Adello Biologics’s competitors?
Formycon, mAbxience, Nevian Lifescience, Genentech, and Bristol-Myers Squibb are some of the 14 competitors of Adello Biologics.
-
When was Adello Biologics acquired?
Adello Biologics was acquired on 03-Jan-2019.
-
Who acquired Adello Biologics?
Adello Biologics was acquired by Kashiv BioSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process